These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 24397259)

  • 21. A prospective, randomized, double-blind study of the tolerability of rifapentine 600, 900, and 1,200 mg plus isoniazid in the continuation phase of tuberculosis treatment.
    Bock NN; Sterling TR; Hamilton CD; Pachucki C; Wang YC; Conwell DS; Mosher A; Samuels M; Vernon A;
    Am J Respir Crit Care Med; 2002 Jun; 165(11):1526-30. PubMed ID: 12045127
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Controlled clinical trial on efficacy of 5-month regimens and whole course intermittent 6-month regimens in treating bacillary pulmonary tuberculosis].
    Chu N; Yan B; Zhu L
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Jul; 21(7):388-91. PubMed ID: 11326873
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel inhalable form of rifapentine.
    Chan JG; Duke CC; Ong HX; Chan JC; Tyne AS; Chan HK; Britton WJ; Young PM; Traini D
    J Pharm Sci; 2014 May; 103(5):1411-21. PubMed ID: 24585270
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel dosing strategies increase exposures of the potent antituberculosis drug rifapentine but are poorly tolerated in healthy volunteers.
    Dooley KE; Savic RM; Park JG; Cramer Y; Hafner R; Hogg E; Janik J; Marzinke MA; Patterson K; Benson CA; Hovind L; Dorman SE; Haas DW;
    Antimicrob Agents Chemother; 2015; 59(6):3399-405. PubMed ID: 25824215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low isoniazid concentrations and outcome of tuberculosis treatment with once-weekly isoniazid and rifapentine.
    Weiner M; Burman W; Vernon A; Benator D; Peloquin CA; Khan A; Weis S; King B; Shah N; Hodge T;
    Am J Respir Crit Care Med; 2003 May; 167(10):1341-7. PubMed ID: 12531776
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Repeated administration of high-dose intermittent rifapentine reduces rifapentine and moxifloxacin plasma concentrations.
    Dooley K; Flexner C; Hackman J; Peloquin CA; Nuermberger E; Chaisson RE; Dorman SE
    Antimicrob Agents Chemother; 2008 Nov; 52(11):4037-42. PubMed ID: 18765687
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB.
    Sharma SK; Sharma A; Kadhiravan T; Tharyan P
    Evid Based Child Health; 2014 Mar; 9(1):169-294. PubMed ID: 25404581
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and Adherence for 12 Weekly Doses of Isoniazid and Rifapentine for Pediatric Tuberculosis Infection.
    Cruz AT; Starke JR
    Pediatr Infect Dis J; 2016 Jul; 35(7):811-3. PubMed ID: 27088582
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and pharmacological hallmarks of rifapentine's use in diabetes patients with active and latent tuberculosis: do we know enough?
    Zheng C; Hu X; Zhao L; Hu M; Gao F
    Drug Des Devel Ther; 2017; 11():2957-2968. PubMed ID: 29066867
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Defining the optimal dose of rifapentine for pulmonary tuberculosis: Exposure-response relations from two phase II clinical trials.
    Savic RM; Weiner M; MacKenzie WR; Engle M; Whitworth WC; Johnson JL; Nsubuga P; Nahid P; Nguyen NV; Peloquin CA; Dooley KE; Dorman SE;
    Clin Pharmacol Ther; 2017 Aug; 102(2):321-331. PubMed ID: 28124478
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Murine pharmacokinetics of rifapentine delivered as an inhalable dry powder.
    Chan JG; Tyne AS; Pang A; McLachlan AJ; Perera V; Chan JC; Britton WJ; Chan HK; Duke CC; Young PM; Traini D
    Int J Antimicrob Agents; 2015 Mar; 45(3):319-23. PubMed ID: 25554469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Considerations in preparing for clinical studies of inhaled rifampicin to enhance tuberculosis treatment.
    Khadka P; Dummer J; Hill PC; Das SC
    Int J Pharm; 2018 Sep; 548(1):244-254. PubMed ID: 29983396
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The early bactericidal activities of rifampin and rifapentine in pulmonary tuberculosis.
    Sirgel FA; Fourie PB; Donald PR; Padayatchi N; Rustomjee R; Levin J; Roscigno G; Norman J; McIlleron H; Mitchison DA
    Am J Respir Crit Care Med; 2005 Jul; 172(1):128-35. PubMed ID: 15805182
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recommendations for use of an isoniazid-rifapentine regimen with direct observation to treat latent Mycobacterium tuberculosis infection.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Dec; 60(48):1650-3. PubMed ID: 22157884
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rifampicin and rifapentine significantly reduce concentrations of bedaquiline, a new anti-TB drug.
    Svensson EM; Murray S; Karlsson MO; Dooley KE
    J Antimicrob Chemother; 2015 Apr; 70(4):1106-14. PubMed ID: 25535219
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A rifapentine-containing inhaled triple antibiotic formulation for rapid treatment of tubercular infection.
    Chan JG; Tyne AS; Pang A; Chan HK; Young PM; Britton WJ; Duke CC; Traini D
    Pharm Res; 2014 May; 31(5):1239-53. PubMed ID: 24242939
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New approaches to the treatment of latent tuberculosis.
    Sterling TR
    Semin Respir Crit Care Med; 2008 Oct; 29(5):532-41. PubMed ID: 18810686
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New drugs for tuberculosis treatment.
    Sánchez F; López Colomés JL; Villarino E; Grosset J
    Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 1():47-56. PubMed ID: 21420567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rifapentine for latent tuberculosis infection treatment in the general population and human immunodeficiency virus-positive patients: summary of evidence.
    Vidal JS; Silva MT; Sanchez MN
    Rev Soc Bras Med Trop; 2015; 48(5):507-13. PubMed ID: 26516958
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of isoniazid in once-weekly rifapentine treatment of pulmonary tuberculosis.
    Mitchison DA
    Am J Respir Crit Care Med; 2003 May; 167(10):1298-9. PubMed ID: 12738593
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.